WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.
Find important updates, industry news, and information on CLSI’s upcoming events. Check out past CLSI press releases, upcoming Committees Week, and newsworthy items.
March 15, 2022
The Clinical and Laboratory Standards Institute (CLSI) has published M100—Performance Standards for Antimicrobial Susceptibility Testing, 32nd Edition.
Read MoreFebruary 17, 2022
CLSI announces the election of three new Board members. Serving as new Directors are Collette Fitzgerald, PhD, Tania Motschman, MS, MT(ASCP)SBB, and Susan Sharp, PhD, D(ABMM), F(AAM).
Read More
February 7, 2022
The Clinical and Laboratory Standards Institute (CLSI) has published the 5th edition of M39—Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data. This guideline describes methods for recording and analyzing antimicrobial susceptibility test data, consisting of cumulative and ongoing summaries of susceptibility patterns of clinically significant microorganisms.
Read MoreJanuary 19, 2022
The Clinical and Laboratory Standards Institute announces the recipients of its 2022 Excellence Awards. These awards celebrate the achievements of CLSI volunteers who have helped improve the quality of medical care worldwide.
Read More
November 29, 2021
The Clinical and Laboratory Standards Institute (CLSI) has published the first edition of guideline EP39—A Hierarchical Approach to Selecting Surrogate Samples for the Evaluation of In Vitro Medical Laboratory Tests.
Read More
November 5, 2021
The Clinical and Laboratory Standards Institute (CLSI) has published the first edition of H62—Validation of Assays Performed by Flow Cytometry.
Read MoreNovember 2, 2021
Glen Fine, the Chief Executive Officer of the Clinical and Laboratory Standards Institute (CLSI), announced he’s retiring effective Spring 2022. For 17 years Fine has served as the head of the globally recognized standards development organization in the field of laboratory medicine.
Read More
October 19, 2021
The Clinical and Laboratory Standards Institute (CLSI) has published the first edition of MM24—Molecular Methods for Genotyping and Strain Typing of Infectious Organisms.
Read More
September 28, 2021
The Clinical and Laboratory Standards Institute (CLSI) has published the first edition of NBS09— Newborn Screening for X-Linked Adrenoleukodystrophy.
Read More
June 11, 2021
The Clinical and Laboratory Standards Institute (CLSI) has published the first edition of C64—Quantitative Measurement of Proteins and Peptides by Mass Spectrometry. C64 provides a framework for developing clinical protein and peptide assays from conception to validation and is intended for those who have experience with traditional small-molecule liquid chromatography–mass spectrometry (LC-MS) but not with protein and peptide analysis.
Read More